Investigating the Diagnostic Potential of Tear Proteins in Cancer - A Pilot Study

Status unconfirmed

Conditions studied: Breast Cancer, Ovarian Cancer, Pancreatic Cancer, Prostate Cancer, Melanoma

In brief

This Pilot Study is to investigate the tear proteins in a multitude of cancer types and indulge in biomarker discovery to manufacture simple, accurate, and novel tear-based diagnostic tests.

Key facts

Study ID

NCT05223218

Run by

Namida Lab

People needed

500

Starts

2021-08-25

Expected to finish

2023-12-01

Last updated by the study team

2023-07-03

Who can join

Age: 18 and older, up to 100. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• 18-100 years of age
• Presenting for the evaluation of an abnormal exam or test (mammogram, ultrasound, MRI, PET, etc.)
• Presenting for the evaluation of a palpable lump or mass
• Presenting with a mass may be pre or post-biopsy/diagnostic as long as there is a portion of the mass remaining.
• Have been diagnosed but have not received treatment

You may not qualify if…

• Less than 18 years of age OR more than 100 years of age
• Concurrent eye infection or trauma
• Acute conjunctivitis

Where it is running

• Namida Lab — Fayetteville, Arkansas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.